Results 41 to 50 of about 3,021 (181)

A randomized, sham-controlled, quintuple-blinded trial to evaluate the NET device as an alternative to medication for promoting opioid abstinence

Contemporary Clinical Trials Communications, 2022
Background: There is an unmet need for non-medication approaches to illicit opioid discontinuation and relapse prevention. The NET (NeuroElectric Therapy) Device is a non-invasive, battery-operated, portable, re-useable device designed to deliver ...
Mark K. Greenwald, Samiran Ghosh, Joe R. Winston   +2 more
doaj   +1 more source

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone [PDF]

Mental Health Clinician, 2021
Introduction: Physician-pharmacist collaborative practice models (PPCPM) decrease barriers and increase access to medications for opioid use disorder (MOUD) but are not routine in practice. The purpose of this quality improvement initiative is to develop
Lindsay M. Mailloux, PharmD, Matthew T. Haas, PharmD, BCPP, BCPS, Janel M. Larew, PharmD, BCPS, Beth M. DeJongh, PharmD, BCPP, BCPS   +3 more
doaj   +1 more source

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and Alcohol Dependence Reports, 2022
Introduction: Psychosocial support is recommended in conjunction with medication for opioid use disorder (MOUD), although optimal “dose,” modality, and timing of participation is not established.
Kathryn Hefner, Tse-Hwei Choo, Dikla Shmueli-Blumberg, Martina Pavlicova, Jacquie King, Marc Fishman, Matisyahu Shulman, Aimee Campbell, Miranda Greiner, Jennifer Scodes, Sarah Meyers-Ohki, Patricia Novo, Edward Nunes, John Rotrosen   +13 more
doaj   +1 more source

"Convenience, Quickness, and Compassion": Experiences of People Involved in the Criminal-Legal System Accessing Medications for Opioid Use Disorder Services From a Mobile Unit in Chicago. [PDF]

Health Expect
ABSTRACT Background This study aimed to explore the experiences of people diagnosed with opioid use disorder (OUD) and recently involved with the criminal‐legal system (CLS) as they received addiction treatment services from a Mobile Medications for Opioid Use Disorder (MOUD) programme in Chicago.
Martinford T, Watson DP, Messmer S, Rashid L, Staton M, Dennis ML, Grella CE, Elmes-Patel A.   +7 more
europepmc   +2 more sources

Initiation of medication for opioid use disorder across a health system: A retrospective analysis of patient characteristics and inpatient outcomes

Drug and Alcohol Dependence Reports, 2022
Objectives: Medication for opioid use disorder (MOUD) has gained significant momentum as an evidence-based intervention for treating opioid use disorder (OUD).
Brian P. O'Rourke, Tory H. Hogan, Julie Teater, Martin Fried, Margaret Williams, Alison Miller, Aaron D. Clark, Phuong Huynh, Emily Kauffman, Jennifer L. Hefner   +9 more
doaj   +1 more source

Smartphone intervention to optimize medication-assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial

Trials, 2023
Background Opioids accounted for 75% of drug overdoses in the USA in 2020, with rural states particularly impacted by the opioid crisis. While medication-assisted treatment (MAT) with Suboxone remains one of the more efficacious treatments for opioid use
Ronald G. Thompson, Mary Bollinger, Michael J. Mancino, Deborah Hasin, Xiaotong Han, Keith A. Bush, Clint D. Kilts, G. Andrew James   +7 more
doaj   +1 more source

699 Inpatient versus outpatient/home initiation of medications for opioid use disorder (MOUD) in pregnancy [PDF]

American Journal of Obstetrics and Gynecology
Courtney Birchall, Brittney Gaudet, Lindsey Issokson, Audrey Lang, Elizabeth Allocco, Katherine Leung, Katherine Callaghan, Ellen Delpapa   +7 more
openalex   +2 more sources

A randomized, parallel group, pragmatic comparative-effectiveness trial comparing medication-assisted treatment induction methods in primary care practices: The HOMER study protocol.

PLoS ONE, 2023
Opioid use disorder (OUD) represents a public health crisis in the United States. Medication for opioid use disorder (MOUD) with buprenorphine in primary care is a proven OUD treatment strategy.
Douglas H Fernald, Donald E Nease, John M Westfall, Bethany M Kwan, L Miriam Dickinson, Ben Sofie, Cory Lutgen, Jennifer K Carroll, David Wolff, Lori Heeren, Maret Felzien, Linda Zittleman   +11 more
doaj   +1 more source

Narrative Review of Opioid Use Disorder Treatment Changes During the COVID-19 Pandemic and Their Impact on American Indian/Alaska Native Communities. [PDF]

Nurs Open
ABSTRACT Background The United States (US) declared drug overdose a public health emergency in 2017. Despite this, two million people reported having an opioid use disorder (OUD) in 2018. However, following the beginning of COVID‐19 there was a 53% increase in overdose deaths, with American Indian/Alaska Native (AI/AN) individuals experiencing the ...
Bingham-Hendricks C, Peters-Mosquera A, Aronowitz SV, Woods C, Aronowitz T.   +4 more
europepmc   +2 more sources

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine

Harm Reduction Journal, 2021
Background Recovery is a multidimensional process that includes health, quality of life, and citizenship. Recovery capital is a strengths-based concept representing the sum of an individual’s resources that support recovery.
Anna Beth Parlier-Ahmad, Mishka Terplan, Dace S. Svikis, Laura Ellis, Caitlin E. Martin   +4 more
doaj   +1 more source